These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8069927

  • 1. Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent.
    Juretic A, Spagnoli GC, von Bremen K, Hörig H, Filgueira L, Lüscher U, Babst R, Harder F, Heberer M.
    Cell Immunol; 1994 Sep; 157(2):462-77. PubMed ID: 8069927
    [Abstract] [Full Text] [Related]

  • 2. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells.
    Cifone MG, Festuccia C, Cironi L, Cavallo G, Chessa MA, Pensa V, Tubaro E, Santoni A.
    Cell Immunol; 1994 Aug; 157(1):181-94. PubMed ID: 7518750
    [Abstract] [Full Text] [Related]

  • 3. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 4. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA, Vujanovic NL, Herberman RB, Hiserodt JC.
    J Immunol; 1988 Apr 15; 140(8):2846-52. PubMed ID: 3258622
    [Abstract] [Full Text] [Related]

  • 5. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
    Mohaupt M, Schoecklmann HO, Schulze-Lohoff E, Sterzel RB.
    J Hypertens; 1994 Apr 15; 12(4):401-8. PubMed ID: 8064164
    [Abstract] [Full Text] [Related]

  • 6. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
    Orucevic A, Lala PK.
    Cell Immunol; 1996 Apr 10; 169(1):125-32. PubMed ID: 8612285
    [Abstract] [Full Text] [Related]

  • 7. Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent.
    Juretic A, Spagnoli GC, Hörig H, Shipman R, Kocher T, Samija M, Turic M, Eljuga D, Harder F, Heberer M.
    Immunology; 1995 Jun 10; 85(2):325-30. PubMed ID: 7642224
    [Abstract] [Full Text] [Related]

  • 8. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway.
    Mills CD.
    J Immunol; 1991 Apr 15; 146(8):2719-23. PubMed ID: 1707918
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
    Yamauchi A, Bloom ET.
    J Immunol; 1993 Nov 15; 151(10):5535-44. PubMed ID: 8228244
    [Abstract] [Full Text] [Related]

  • 12. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine.
    Lee QP, Juchau MR.
    Teratology; 1994 Jun 15; 49(6):452-64. PubMed ID: 7538231
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis.
    Efron DT, Kirk SJ, Regan MC, Wasserkrug HL, Barbul A.
    Surgery; 1991 Aug 15; 110(2):327-34. PubMed ID: 1858040
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
    Wang ZP, Chen YR, Zheng RL, Lu JZ, Wang JJ.
    Acta Pharmacol Sin; 2002 Mar 15; 23(3):257-62. PubMed ID: 11918852
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo.
    Fecho K, Maslonek KA, Coussons-Read ME, Dykstra LA, Lysle DT.
    J Immunol; 1994 Jun 15; 152(12):5845-52. PubMed ID: 8207211
    [Abstract] [Full Text] [Related]

  • 18. The role of NO in macrophage dysfunction at early stage after burn injury.
    Luo G, Peng D, Zheng J, Chen X, Wu J, Elster E, Tadaki D.
    Burns; 2005 Mar 15; 31(2):138-44. PubMed ID: 15683683
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
    Kaplan JM, Badger AM, Ruggieri EV, Olivera DL, Newman-Tarr T, Bugelski PJ.
    J Clin Lab Immunol; 1991 Dec 15; 36(4):49-58. PubMed ID: 1668843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.